Skip to main content

Table 2 Maspin expression in prostate cancer

From: Role of maspin in cancer

Authors Years N. patients Maspin expression Clinical features/prognosis
Lovric et al. 2010 34 prostate cancer 79% positive maspin with nuclear expression  
Riddick et al. 2005 44 prostate cancer Not found Positive maspin = lower Gleason score
Machtens et al. 2001 84 prostate cancer 58% positive maspin Positive maspin = OS: 78 months, PFS: 41 months, GIII-IV: 23%, N1/N2: 9% OS = 62 months, PFS = 26 months, GIII-IV = 48%, N1/N2 = 18%
18% negative maspin
Zou et al. 2002 97 prostate cancer 40.2% positive maspin Positive maspin = 91.7% partial response with neoadjuvant therapy
    49.8% negative maspin